Stock Analysis

Some Investors May Be Willing To Look Past Hancom Lifecare's (KRX:372910) Soft Earnings

KOSE:A372910
Source: Shutterstock

Soft earnings didn't appear to concern Hancom Lifecare Inc.'s (KRX:372910) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.

View our latest analysis for Hancom Lifecare

earnings-and-revenue-history
KOSE:A372910 Earnings and Revenue History May 21st 2024

How Do Unusual Items Influence Profit?

For anyone who wants to understand Hancom Lifecare's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by ₩830m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Hancom Lifecare to produce a higher profit next year, all else being equal.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Hancom Lifecare's Profit Performance

Unusual items (expenses) detracted from Hancom Lifecare's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Hancom Lifecare's statutory profit actually understates its earnings potential! Unfortunately, though, its earnings per share actually fell back over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For example, we've discovered 2 warning signs that you should run your eye over to get a better picture of Hancom Lifecare.

Today we've zoomed in on a single data point to better understand the nature of Hancom Lifecare's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Valuation is complex, but we're here to simplify it.

Discover if Hancom Lifecare might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.